FINWIRES · TerminalLIVE
FINWIRES

MediPharm Reports Positive Phase 2 LiBBY Trial Results in Patients With Advanced Dementia

By

MediPharm Labs (LABS.TO) on Tuesday reported positive results from a Phase II trial evaluating the company's oral cannabinoid formulation for the treatment of agitation in patients with advanced dementia.

The LiBBY (Life's End Benefits of Cannabidiol and Tetrahydrocannabinol) trial met its primary endpoint and showed statistically significant improvements in agitation symptoms compared with placebo. Benefits were seen as early as two weeks and sustained throughout the 12-week treatment period, a statement added.

The findings were reported for the first time at the Alzheimer's Association International Conference (AAIC) 2026 in London, UK.

MediPharm is reviewing the full study results and evaluating potential next steps.

The company's shares were last seen unchanged at C$0.075 on the Toronto Stock Exchange.

Related Articles

Mining & Metals

Alphamin Resources Expects Second-Quarter EBITDA of $167 Million

Alphamin Resources (AFM.V) after trade Monday said it expects to report second-quarter EBITDA of about $167 million, up 6% from the previous quarter.The company added the increase is driven by a 5% jump in the average tin price to $51,957 per tonne from $49,278 per tonne. Current tin prices are around $53,000 per tonne.Alphamin also said it produced 5,013 tonnes of tin and sold 5,014 tonnes during the quarter, in line with its annual production target of 20,000 tonnes.All-in sustaining costs are expected to rise 6% to $19,043 per tonne "due to a combination of off-mine costs in the form of increased royalties, export duties, marketing commissions and net smelter returns, which increase as tin price increases, and timing on capital expenditure," the company said.The company added that its unaudited consolidated financial statements for the three and six months ended 30 June are set to be released around July 31.Alphamin shares unchanged at C$1,38 on the TSX Venture Exchange.

$AFM.V
Mining & Metals

Artemis Gold Reports Record Q2 Production at Blackwater Mine

Artemis Gold (ARTG.V) after market close on Monday said its second-quarter gold production at its Blackwater mine in British Columbia rose 20% from the previous quarter to a record 74,063 ounces.The increase was driven by higher feed grades, improved gold recoveries and stronger mill throughput, the company said.Blackwater produced 135,986 ounces of gold in the first half of 2026, with full-year production guidance unchanged at 265,000 to 290,000 ounces.Company's shares closed C$1.51 down, or 4.6% to C$31.47 on TSX Venture Exchange on Monday.

$ARTG.V
Mining & Metals

Aecon Group-Backed TerraMarine Named Preferred Proponent for Roberts Bank Terminal 2

TerraMarine, a consortium in which Aecon Group (ARE.TO) holds a 30% interest, has been selected as the preferred proponent for the Roberts Bank Terminal 2 Landmass and Wharf project in Delta, British Columbia, the company said Monday.TerraMarine is expected to sign an agreement with the Vancouver Fraser Port Authority in the third quarter of 2026. A design-build agreement is expected to follow in the first quarter of 2028, with construction slated for completion in the mid-2030s.The project will boost container capacity at the Port of Vancouver by 30%, delivering a new three-berth marine container terminal at Canada's largest port and creating 320 acres of new waterfront industrial land, the company said.Aecon shares closed down C$0.33 to C$48.29 on Toronto Stock Exchange on Monday.

$ARE.TO